BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20167690)

  • 1. Early prostate cancer antigen-2: a controversial prostate cancer biomarker?
    Diamandis EP
    Clin Chem; 2010 Apr; 56(4):542-4. PubMed ID: 20167690
    [No Abstract]   [Full Text] [Related]  

  • 2. Digital rectal examination-associated alterations in serum prostate-specific antigen.
    Gillenwater JY
    Am J Clin Pathol; 1992 Apr; 97(4):466-7. PubMed ID: 1372786
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate-specific antigen. Improving its ability to diagnose early prostate cancer.
    Oesterling JE
    JAMA; 1992 Apr 22-29; 267(16):2236-8. PubMed ID: 1372945
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of prostate cancer: a personal view.
    Stamey TA
    J Urol; 1992 Mar; 147(3 Pt 2):830-2. PubMed ID: 1371556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Related biomarkers in the diagnosis of prostate cancer].
    Xu YM; Liu HZ
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [[Is the PCA3 cost-effective in Latin America and the Caribbean?]].
    Grández-Urbina JA; Pichardo-Rodríguez R; Saldaña-Gallo J
    Salud Publica Mex; 2018; 60(1):104-105. PubMed ID: 29689669
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.
    Marrink J; Oosterom R; Bonfrer HM; Schröder FH; Mensink HJ
    Eur J Cancer; 1993; 29A(4):570-1. PubMed ID: 7679580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.
    Adeola HA; Smith M; Kaestner L; Blackburn JM; Zerbini LF
    Oncotarget; 2016 Mar; 7(12):13945-64. PubMed ID: 26885621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prostate-specific antigen: the most useful tumor marker.
    Andriole GL
    J Clin Oncol; 1992 Aug; 10(8):1205-7. PubMed ID: 1378885
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate specific antigen.
    Med Lett Drugs Ther; 1992 Oct; 34(880):93-4. PubMed ID: 1381807
    [No Abstract]   [Full Text] [Related]  

  • 12. Seminal fluid: a useful source of prostate cancer biomarkers?
    Roberts MJ; Richards RS; Gardiner RA; Selth LA
    Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
    Taneja SS
    J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate].
    Morote J; de Torres JA
    Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
    Mazzola CR; Ghoneim T; Shariat SF
    Prog Urol; 2011 Jan; 21(1):1-10. PubMed ID: 21193139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.
    Benson MC; Whang IS; Pantuck A; Ring K; Kaplan SA; Olsson CA; Cooner WH
    J Urol; 1992 Mar; 147(3 Pt 2):815-6. PubMed ID: 1371554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will emerging prostate cancer markers redeem themselves?
    Hotakainen K; Stenman UH
    Clin Chem; 2010 Aug; 56(8):1212-3. PubMed ID: 20570933
    [No Abstract]   [Full Text] [Related]  

  • 18. Nondetectable prostate-specific antigen in moderately differentiated adenocarcinoma of prostate.
    Daugherty RL; Cos LR; Keller JW; di Sant'Agnese A
    Urology; 1992 Jun; 39(6):552-5. PubMed ID: 1377434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostate specific antigen as pre-screening test for prostate cancer.
    Labrie F; Dupont A; Suburu R; Cusan L; Tremblay M; Gomez JL; Emond J
    J Urol; 1992 Mar; 147(3 Pt 2):846-51; discussion 851-2. PubMed ID: 1371560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on the article "Biomarkers for prostate cancer" by Eric Schiffer.
    Marshall S
    World J Urol; 2009 Aug; 27(4):577-8. PubMed ID: 19543735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.